journal article·2026-03Open access

Polydopamine‐Antibiotic Composite Coating for Antibiofilm Applications

Gillian A. Kropp, Hannah Q. Karp, Jayasimha Rao, Henriette Suzanne Muller, Nammalwar Sriranganathan, Elizabeth S. Nowak, Michael D. Schulz

Macromolecular Bioscience· Volume 26· Issue 3

Abstract

ABSTRACT Urinary catheterization is a common procedure, affecting 15%–25% of hospitalized patients. This procedure, however, often results in bacterial infections, primarily caused by biofilm‐forming Gram‐negative bacteria that adhere to the catheter surface. To address this challenge, we developed a polymer‐based antimicrobial coating using polydopamine (PD) embedded with gentamicin (Gent). We evaluated the antibiofilm efficacy of this coating (PD‐Gent) using a biofilm‐forming isolate of Pseudomonas aeruginosa (PAO1) as P. aeruginosa is commonly implicated in catheter‐related infections. We observed that the PD‐Gent coating significantly reduced biofilm formed by PAO1 compared to the uncoated control. Importantly, the coating maintained its antibiofilm activity across diverse substrates, including polystyrene, poly(vinyl chloride), and silicone. The approach was further extended to incorporate other antibiotics (tobramycin, amikacin), demonstrating adaptability to multiple antimicrobial agents. Finally, artificial urine inoculated with PAO1 was deployed through PD‐Gent–coated silicone Foley catheters under continuous flow for 24 h. Despite this continuous introduction of PAO1, the coated catheters inhibited biofilm formation by three‐fold compared to the uncoated control catheters. These findings underscore the promise of PD‐Gent as a robust, versatile coating with strong potential to significantly reduce the incidence of catheter‐associated infections in clinical settings.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Urinary Tract Infections Management · Polymer Surface Interaction Studies · Antimicrobial agents and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry Virginia Tech Blacksburg Virginia USA

Virginia Tech Carilion School of Medicine Roanoke Virginia USA

Division of Infectious Diseases Carilion Clinic Roanoke Virginia USA

Translational Biology, Medicine, and Health Graduate Program Virginia Tech Blacksburg Virginia USA

Center for Emerging, Zoonotic, and Arthropod‐borne Pathogens Virginia Tech Blacksburg Virginia USA

Department of Biomedical Sciences and Pathobiology Center for Molecular Medicine and Infectious Diseases Virginia‐Maryland Regional College of Veterinary Medicine Virginia Tech Blacksburg Virginia USA

Macromolecules Innovation Institute Blacksburg Virginia USA

Funding

Carilion Clinic

References (52)

Show source-provided references
1. 10.1016/j.jiph.2019.09.00910.1016/j.jiph.2019.09.009 ↗
2. Catheter Associated Urinary Tract Infections
3. 10.1310/sci2503-22810.1310/sci2503-228 ↗
4. 10.1186/s12894‐024‐01565‐x10.1186/s12894‐024‐01565‐x ↗
5. 10.1038/ijos.2014.6510.1038/ijos.2014.65 ↗
6. 10.1016/j.cegh.2023.10129110.1016/j.cegh.2023.101291 ↗
7. 10.1172/jci.insight.16146110.1172/jci.insight.161461 ↗
8. 10.1016/j.heliyon.2019.e0298610.1016/j.heliyon.2019.e02986 ↗
9. 10.1038/s41467‐023‐44095‐010.1038/s41467‐023‐44095‐0 ↗
10. 10.1039/d3tb00819c10.1039/d3tb00819c ↗
11. 10.1039/D1SC05835E10.1039/D1SC05835E ↗
12. 10.1038/nbt.163110.1038/nbt.1631 ↗
13. 10.1021/acs.biomac.3c0015010.1021/acs.biomac.3c00150 ↗
14. 10.3390/bioengineering1002021810.3390/bioengineering10020218 ↗
15. 10.3389/fchem.2024.146918310.3389/fchem.2024.1469183 ↗
16. 10.1016/j.nantod.2024.10215110.1016/j.nantod.2024.102151 ↗
17. 10.1021/acs.molpharmaceut.1c0003010.1021/acs.molpharmaceut.1c00030 ↗
18. 10.1021/acs.biomac.2c0143110.1021/acs.biomac.2c01431 ↗
19. 10.1016/j.jconrel.2019.11.03110.1016/j.jconrel.2019.11.031 ↗
20. 10.1021/acsabm.1c0092610.1021/acsabm.1c00926 ↗
21. 10.3390/molecules2811425810.3390/molecules28114258 ↗
22. 10.1016/j.actbio.2012.07.00510.1016/j.actbio.2012.07.005 ↗
23. 10.1039/D0MH01985B10.1039/D0MH01985B ↗
24. 10.1021/acsami.9b2204310.1021/acsami.9b22043 ↗
25. 10.1016/j.actbio.2014.12.01510.1016/j.actbio.2014.12.015 ↗
26. 10.1038/s41467‐023‐36303‐810.1038/s41467‐023‐36303‐8 ↗
27. 10.1016/j.colsurfb.2021.11197210.1016/j.colsurfb.2021.111972 ↗
28. 10.1308/rcsann.2023.000310.1308/rcsann.2023.0003 ↗
29. 10.1016/j.conbuildmat.2025.14204510.1016/j.conbuildmat.2025.142045 ↗
30. 10.1021/la402028810.1021/la4020288 ↗
31. 10.1002/marc.20220094610.1002/marc.202200946 ↗
32. 10.1016/j.cellimm.2011.04.01110.1016/j.cellimm.2011.04.011 ↗
33. 10.1016/j.jcis.2012.07.03010.1016/j.jcis.2012.07.030 ↗
34. 10.1007/s40121‐021‐00570‐z10.1007/s40121‐021‐00570‐z ↗
35. 10.1128/aac.02165‐1810.1128/aac.02165‐18 ↗
36. 10.1016/j.cmicom.2024.10503910.1016/j.cmicom.2024.105039 ↗
37. 10.3390/antibiotics1205086010.3390/antibiotics12050860 ↗
38. 10.3390/microorganisms1308194810.3390/microorganisms13081948 ↗
39. 10.1016/j.isci.2025.11207610.1016/j.isci.2025.112076 ↗
40. 10.1126/sciadv.ads500510.1126/sciadv.ads5005 ↗
41. 10.1093/jac/dkv42810.1093/jac/dkv428 ↗
42. 10.1016/s0891‐5520(03)00066‐710.1016/s0891‐5520(03)00066‐7 ↗
43. 10.1128/aac.00694‐1110.1128/aac.00694‐11 ↗
44. 10.1371/journal.pone.021121410.1371/journal.pone.0211214 ↗
45. Crystal Violet Binding Assay for Assessment of Biofilm Formation by Isolates of Listeria monocytogenes and Listeria spp from a Typical Tropical Abattoir on Wood, Steel and Glass Surfaces
46. 10.1007/978-1-0716-1550-8_910.1007/978-1-0716-1550-8_9 ↗
47. Quantitative and Qualitative Assessment Methods for Biofilm Growth: a Mini‐review
48. 10.1007/s00284‐016‐1081‐110.1007/s00284‐016‐1081‐1 ↗
49. 10.3390/ma1519672710.3390/ma15196727 ↗
50. 10.1002/9780471729259.mc01b01s0010.1002/9780471729259.mc01b01s00 ↗
51. 10.1128/jb.00797‐0810.1128/jb.00797‐08 ↗
52. 10.1007/s11255‐016‐1262‐710.1007/s11255‐016‐1262‐7 ↗